Protein Interaction and Functional Data Indicate MTHFD2 Involvement in RNA Processing and Translation
Overview
Authors
Affiliations
Background: The folate-coupled metabolic enzyme MTHFD2 is overexpressed in many tumor types and required for cancer cell proliferation, and is therefore of interest as a potential cancer therapeutic target. However, recent evidence suggests that MTHFD2 has a non-enzymatic function which may underlie the dependence of cancer cells on this protein. Understanding this non-enzymatic function is important for optimal targeting of MTHFD2 in cancer.
Methods: To identify potential non-enzymatic functions of MTHFD2, we defined its interacting proteins using co-immunoprecipitation and mass spectrometry and integrated this information with large-scale co-expression analysis, protein dynamics, and gene expression response to MTHFD2 knockdown.
Results: We found that MTHFD2 physically interacts with a set of nuclear proteins involved in RNA metabolism and translation, including components of the small ribosomal subunit and multiple members of the RNA-processing hnRNP family. Interacting proteins were also in general co-expressed with MTHFD2 in experiments that stimulate or repress proliferation, suggesting a close functional relationship. Also, unlike other folate one-carbon enzymes, the MTHFD2 protein has a short half-life and responds rapidly to serum. Finally, shRNA against MTHFD2 depletes several of its interactors and yields an overall transcriptional response similar to targeted inhibition of certain ribosomal subunits.
Conclusions: Taken together, our findings suggest a novel function of MTHFD2 in RNA metabolism and translation.
Lertwanakarn T, Khemthong M, Setthawong P, Phaonakrop N, Roytrakul S, Ploypetch S PeerJ. 2025; 13:e18923.
PMID: 39995988 PMC: 11849505. DOI: 10.7717/peerj.18923.
Nuclear localization of MTHFD2 is required for correct mitosis progression.
Pardo-Lorente N, Gkanogiannis A, Cozzuto L, Ganez Zapater A, Espinar L, Ghose R Nat Commun. 2024; 15(1):9529.
PMID: 39532843 PMC: 11557897. DOI: 10.1038/s41467-024-51847-z.
Selectivity analysis of diaminopyrimidine-based inhibitors of MTHFD1, MTHFD2 and MTHFD2L.
Jha V, Eriksson L Sci Rep. 2024; 14(1):21073.
PMID: 39256448 PMC: 11387627. DOI: 10.1038/s41598-024-71879-1.
Marttila P, Bonagas N, Chalkiadaki C, Stigsdotter H, Schelzig K, Shen J Mol Oncol. 2024; 18(9):2179-2195.
PMID: 38533616 PMC: 11467796. DOI: 10.1002/1878-0261.13645.
Wu S, Cai W, Li Y, Tan W, Yuan Y, Zhou Z Int J Med Sci. 2023; 20(8):1097-1113.
PMID: 37484807 PMC: 10357439. DOI: 10.7150/ijms.81962.